This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay D is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Rebeccca had suffered for years from major depression. She had taken antidepressants and undergone pyschotherapy, but nothing helped. Rebecca realized she had treatment resistant depression, but didn’t know what to do. Recently, she underwent TMS Therapy with Brainsway® Deep TMS. “The machine has been a game changer for Rebecca’s mental health.” She can now find joy in life, and enjoys living in the moment.
Read the full story here.